Robert Bermel, M.D.
| Appointed: |
2008 |
| Gender: |
Male |
| Languages: |
English |
Mellen Center
Neurology
Biographical Sketch
Robert Bermel, MD is Associate Staff in the Neurological Institute's Mellen Center for Multiple Sclerosis at Cleveland Clinic. He received a medical degree with thesis honors from the State University of New York at Buffalo, where his interest in MS began while training under Dr. Lawrence Jacobs. Dr. Bermel completed neurology residency training and served as Chief Resident at Cleveland Clinic. He was funded as a National MS Society postdoctoral fellow in clinical neuroimmunology and advanced imaging at Cleveland Clinic.
Dr. Bermel cares for patients, conducts imaging research, and participates in clinical trials at the Mellen Center. His current research interests focus on the identification of advanced imaging methods to evaluate and improve recovery from inflammatory demyelinating disease. Specifically, he is utilizing techniques such as Optical Coherence Tomography (OCT), Diffusion Tensor MRI (DTI), and Functional MRI (fMRI). He is currently principal investigator on a research grant funded by the National MS Society, and a co-investigator on multiple clinical trials.
He regularly serves as a volunteer speaker to patient groups on behalf of the National MS Society, and occasionally as a consultant to industry in the field of MS therapeutics.
Professional Highlights
- National Multiple Sclerosis Society Research Grant: "Advanced imaging methods to study recovery from acute optic neuritis"
- Program Committee - American Society of Neuroimaging
- Regular volunteer speaker for the National Multiple Sclerosis Society
Education & Fellowships
| Medical School: | State University of New York School of Medicine and Biomedical Sciences, Buffalo, NY |
|
| Internship: | Cleveland Clinic, Internal Medicine, Cleveland, OH |
| Residency: | Cleveland Clinic, Neurology, Cleveland, OH |
| Fellowship: | Cleveland Clinic, neuroimmunology, Cleveland, OH |
| Other Education: | (Undergraduate) State University of New York (SUNY) at Buffalo, Buffalo, NY |
Certifications
Specialty Interests
Clinical trial research, imaging research, Multiple Sclerosis, Neuroimmunology.
Awards & Honors
- 2003 American Society of Neuroimaging William Oldendorf Award for Outstanding Neuroimaging Research. Presented at the ASN Annual Meeting, New Orleans, LA March 7, 2003 for the work entitled: "Gray matter T2 hypointensity predicts longitudinal brain atrophy in MS: effect of interferon beta-1a".
- 2003 American Academy of Neurology Medical Student Prize for Excellence in Neurology. Presented at University at Buffalo School of Medicine commencement May 23, 2003.
- 2003 State University of New York at Buffalo Baccelli Award for Most Outstanding Research. Presented at University at Buffalo School of Medicine commencement May 23, 2003.
- 2001 American Academy of Neurology G. Milton Shy Award in Clinical Neurology. Presented at the AAN Annual Meeting, Philadelphia, PA May 7, 2001 for the work entitled: "Bicaudate ratio as a marker of brain atrophy in multiple sclerosis".
Professional Memberships
- American Academy of Neurology - member since 2000
- American Medical Association - member since 1999
- American Society of Neuroimaging - member since 2001. Annual Meeting Program Committee since 2003
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 5/29/2009 the review process regarding Dr. Bermel’s disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
